1.
Myo-kyoung Kim, Joo-Youn Cho, Hyeong-Seok
Lim, Kyoung-Seop Hong, Jae-Yong Chung, Kyun-Seop
Bae, Dal-Seok Oh, Sang-Goo Shin, Sang-Hun
Lee, Dong-Ho Lee, Bumchan Min, In-Jin Jang.
Effect of the CYP2d6 genotype on the pharmacokinetics
of tropisetron in healthy Korean subjects.
Eur J Clin Pharmacol 2003, Jun(59):111-116
2. Kim TY, Kim DW, Chung JY, Shin SG, Kim
SC, Heo DS, Kim NK, Bang YJ. Phase I and
pharmacokinetic study of Genexol-PM, a cremophor-free,
polymeric micelle-formulated paclitaxel,
in patients with advanced malignancies.
Clin Cancer Res. 2004 Jun 1;10(11):3708-16.
3. Yu KS, Cho JY, Jang IJ, Hong KS, Chung
JY, Kim JR, Lim HS, Oh DS, Yi SY, Liu KH,
Shin JG, Shin SG. Effect of the CYP3A5 Genotype
on the Pharmacokinetics of Intravenous Midazolam
During Inhibited and Induced Metabolic States.
Clin Pharmacol Ther 2004 Aug;76(2):104-12.
4. Cho JY, Lim HS, Chung JY, Yu KS, Kim
JR, Shin SG, Jang IJ. Haplotype structure
and allele frequencies of CYP2B6 in a Korean
population. Drug Metab Dispos 2004 32(12):1341-4.
5. Yi SY, Hong KS, Lim HS, Chung JY, Oh
DS, Kim JR, Jung HR, Cho JY, Yu KS, Jang
IJ, Shin SG. A variant 2677A allele of the
MDR1 gene affects fexofenadine disposition.
Clin Pharmacol Ther 2004 ;76(5):418-27.
6. Yu KS, Bae KS, Shon JH, Cho JY, Yi SY,
Chung JY, Lim HS, Jang IJ, Shin SG, Song
KS, Moon BS. Pharmacokinetic and pharmacodynamic
evaluation of a novel proton pump inhibitor,
YH1885, in healthy volunteers. J Clin Pharmacol.
2004 Jan;44(1):73-82.
7. Chung JY, Cho JY, Yu KS, Kim JR, Jung
HR, Lim KS, Jang IJ, Shin SG. Effect of
UGT2B15 genotype on the pharmacokinetics,
pharmacodynamics, and drug interactions
of intravenous lorazepam in healthy volunteers.
Clin Pharmacol Ther 2005;77:486-94.
8. Chung JY, Cho JY, Yu KS, Kim JR, Oh
DS, Jung HR, Lim KS, Moon KH, Shin SG, Jang
IJ.
Effect of OATP1B1 (SLCO1B1) variant alleles
on the pharmacokinetics of pitavastatin
in healthy volunteers. Clin Pharmacol Ther.
2005 Oct;78(4):342-50.
9. Lim HS, Cho JY, Oh DS, Chung JY, Hong
KS, Bae KS, Yu KS, Lee KH, Jang IJ, Shin
SG. AngiotensinII type 1 receptor 1166A/C
polymorphism in association with blood pressure
response to exogenous angiotensin II. Eur
J Clin Pharmacol. 2007;63(1):17-26.
10. Kim BH, Lim HS, Chung JY, Kim JR, Lim
KS, Sohn DR, Cho JY, Yu KS, Shin SG, Paick
JS, Jang IJ. Safety, tolerability and pharmacokinetics
of udenafil, a novel PDE-5 inhibitor, in
healthy young Korean subjects. Br J Clin
Pharmacol. 2008 Jun;65(6):848-54.
11. Chung JY, Cho JY, Yu KS, Kim JR, Lim
KS, Sohn DR, Shin SG, Jang IJ. Pharmacokinetic
and Pharmacodynamic Interaction of Lorazepam
and Valproic Acid in Relation to UGT2B7
Genetic Polymorphism in Healthy Subjects.
Clin Pharmacol Ther. 2008;83(4):595-600
12. Chung JY, Lee YJ, Jang SB, Lim LA,
Park MS, Kim KH: CYP3A5*3 genotype associated
with intrasubject pharmacokinetic variation
toward tacrolimus in bioequivalence study.
Ther Drug Monit 2010; 32(1): 67-72
13. Lee YJ, Lee MG, Lim LA, Jang SB, Chung
JY: Effects of SLCO1B1 and ABCB1 genotypes
on the pharmacokinetics of atorvastatin
and 2-hydroxyatoryastatin in healthy Korean
subjects. Int J Clin Pharmaco Therapeu 2010;
48(1): 36-45
|
